Related Experiment Video

Updated: Jul 29, 2026

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
13:22

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System

Published on: September 10, 2013

12.1K

A novel model system to predict efficacy and safety of dexamethasone

Lawrence H Lash1

  • 1Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan.

The Journal of Pharmacology and Experimental Therapeutics
|July 5, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DexamethasoneDrug-drug interactionsHumanized mousePharmacokinetics

More Related Videos

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.8K
A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
08:04

A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies

Published on: January 24, 2020

12.6K

Related Experiment Videos

Last Updated: Jul 29, 2026

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System
13:22

A Chemical Screening Procedure for Glucocorticoid Signaling with a Zebrafish Larva Luciferase Reporter System

Published on: September 10, 2013

12.1K
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.8K
A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies
08:04

A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies

Published on: January 24, 2020

12.6K

Related Concept Videos

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

Articles linked to this work by shared authors, journal, and citation graph.

Trichloroethylene: An Update on an Environmental Contaminant with Multiple Health Effects.

Annual review of pharmacology and toxicology·2024

Renal Glutathione: Dual roles as antioxidant protector and bioactivation promoter.

Biochemical pharmacology·2024

Naturally occurring autoimmune disease in (NZB × NZW) F1 mice is correlated with suppression of MZ B-cell development due to aberrant B-cell receptor (BCR) signaling, which is exacerbated by exposure to inorganic mercury.

Toxicological sciences : an official journal of the Society of Toxicology·2023

N-Acetyl-L-cysteine and aminooxyacetic acid differentially modulate toxicity of the trichloroethylene metabolite S-(1,2-dichlorovinyl)-L-cysteine in human placental villous trophoblast BeWo cells.

Toxicology·2023

Cellular and Functional Biomarkers of Renal Injury and Disease.

Current opinion in toxicology·2022

Unexpected Enhancement of Cytotoxicity of Cisplatin in a Rat Kidney Proximal Tubular Cell Line Overexpressing Mitochondrial Glutathione Transport Activity.

International journal of molecular sciences·2022

Risk of liver adverse events with nivolumab/ipilimumab combination therapy for hepatocellular carcinoma: A disproportionality analysis based on the Food and Drug Administration Adverse Event Reporting System data base.

The Journal of pharmacology and experimental therapeutics·2026

Aryl hydrocarbon receptor as a molecular mediator in the induction of human aldehyde oxidase gene expression.

The Journal of pharmacology and experimental therapeutics·2026

CircDOPEY2 promotes prostate cancer metastasis via inhibiting heterogeneous nuclear ribonucleoprotein M ubiquitination to stabilize intercellular adhesion molecule 2 mRNA.

The Journal of pharmacology and experimental therapeutics·2026

Placenta-derived mesenchymal stem cells attenuate acute brain injury and neuroinflammation after intracerebral hemorrhage.

The Journal of pharmacology and experimental therapeutics·2026

Interoceptive effects of N1-substituted lysergamides in rats: Role of agonist affinity at 5-hydroxytryptamine receptors and in vivo metabolism to lysergic acid diethylamide.

The Journal of pharmacology and experimental therapeutics·2026

Safety, pharmacodynamics, and pharmacokinetics of oral cannabigerol in healthy adults.

The Journal of pharmacology and experimental therapeutics·2026

Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections.

Journal of clinical pharmacology·2026

[Drug Discovery - A surge in innovation driven by technology and artificial intelligence].

Therapeutische Umschau. Revue therapeutique·2026

Efficacy of nipocalimab in patients with moderate-to-severe ocular symptoms of generalized myasthenia gravis in the phase 3 Vivacity-MG3 study.

Expert opinion on biological therapy·2026

Real-world experience with foslevodopa/foscarbidopa in Germany: therapeutic insights and lessons learned.

Neurological research and practice·2026

Exposure Robustness by Design: a translational framework for oral drug product development.

Drug discovery today·2026

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Neuroscience·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us